Evidence map›Paper›PMID 41858916›Full record

ReviewDrug design, development and therapy2026

Medicinal Plants That Modulate Nitric Oxide Synthase Activity: Implications in Inflammation and Oxidative Stress.

Deshanda Kurniawan Prayoga, Diah Lia Aulifa, Arif Budiman, Supat Jiranusornkul, Jutti Levita

Abstract readReview
In one paragraph

Review in Drug design, development and therapy, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Deshanda Kurniawan Prayoga *Doctoral Program in Pharmacy, Faculty of Pharmacy, Universitas Padjadjaran, Sumedang, West Java, Indonesia.
Diah Lia Aulifa *Department of Pharmaceutical Analysis and Medicinal Chemistry, Faculty of Pharmacy, Universitas Padjadjaran, Sumedang, West Java, Indonesia.ORCID 0000-0001-8779-8972
Arif Budiman *Department of Pharmaceutics and Pharmaceutical Technology, Faculty of Pharmacy, Universitas Padjadjaran, Sumedang, West Java, Indonesia.
Supat Jiranusornkul *Department of Pharmaceutical Science, Faculty of Pharmacy, Chiang Mai University, Chiang Mai, Thailand.
Jutti Levita *Department of Pharmacology and Clinical Pharmacy, Faculty of Pharmacy, Universitas Padjadjaran, Sumedang, West Java, Indonesia.ORCID 0000-0002-4578-4174

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Nitric oxide (NO) plays a central role in diverse physiological processes, such as cardiovascular tone, neurotransmission, immune defense, and cellular apoptosis. NO synthase (NOS) is the enzyme that catalyzes the conversion of L-arginine to L-citrulline and NO. Three isoforms of NOS are (1) neuronal NOS (nNOS), which regulates synaptic plasticity, memory formation, and cerebral blood flow, (2) endothelial NOS (eNOS), which supports cardiovascular homeostasis by preventing platelet aggregation and leukocyte adhesion, and (3) inducible NOS (iNOS), which contributes to inflammation and tissue damage, when in excessive production. Thus, targeting iNOS without interfering with the beneficial actions of nNOS and eNOS remains a major therapeutic challenge. Given this dual nature of NO in health and disease, it is important to understand how medicinal plants and their phytochemicals modulate NO pathways. A systematic search of Scopus and PubMed databases was performed for studies published in the last ten years. Screening by title, abstract, and full text yielded 35 eligible articles examining medicinal plants and phytochemicals that influence NO signaling pathways. Preclinical evidence indicates that phytochemicals restore antioxidant defenses and suppress excessive NO and oxidative stress under inflammatory conditions while preserving or enhancing endothelial NO bioavailability. Emerging clinical findings further suggest significantly greater insulin-stimulated NO production and eNOS activation without activating iNOS or promoting inflammatory responses. Their ability to regulate NO production underscores their potential in the development of botanical drugs targeting iNOS while preserving the physiological roles of nNOS and eNOS. This review provides an overview of the potential of medicinal plants to alleviate inflammation and oxidative stress through modulation of NO production.

Indexed as

InflammationNitric Oxide SynthaseOxidative StressPhytochemicalsPlants, MedicinalAnimalsHumansNitric OxideNitric OxideNitric Oxide SynthasePhytochemicalsclinical studyiNOSmedicinal plantsNOSphytochemicals

Identifiers

PMID41858916
PMCPMC12997046

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.